| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $726K | -19.1% |
| SG&A Expense | $2.8M | +65.7% |
| Operating Income | -$3.6M | +29.8% |
| Interest Expense | $17K | +3.6% |
| Net Income | -$3.6M | +29.5% |
| EPS (Basic) | -$1.59 | +40.2% |
| EPS (Diluted) | -$1.59 | +40.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Total Assets | $1.1M | -73.4% |
| Current Liabilities | $318K | +1.4% |
| Stockholders' Equity | $827K | -79.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.2M | +26.3% |
| Financing Cash Flow | $3.1M | +0.0% |